| December 27,2007 |
Astellas Won the Patent Infringement Suit on
Oral Cephalosporin Antibiotic Cefzon® Capsule
(PDF 34KB) |
| December 18,2007 |
Announcement of the Launch of the Pulmonary Arterial Hypertension Agent Careload® LA Tablets 60μg in Japan
(PDF 115KB) |
| November 30,2007 |
Sanofi-aventis and Astellas to restructure their joint venture activities of Fujisawa sanofi-aventis K.K. in Japan
(PDF 25KB) |
| November 29,2007 |
Posted Presentation Mateirial for Press Conference held on Novevmer 28, 2007
(PDF 630KB) |
| November 27,2007 |
Astellas to Acquire Agensys, Inc.
(PDF 382KB) |
| November 22,2007 |
Astellas Announces Acquisition of Treasury Shares
(PDF 24KB) |
| November 14,2007 |
SNDA FOR A FAST-ACTING POSTPRANDIAL HYPOGLICEMIC AGENT
FASTIC® TABLET / STARSIS® TABLET
FOR COMBINATION THERAPY WITH BIGUANIDE WAS APPROVED
(PDF 35KB) |
| November 8,2007 |
Astellas and Boehringer Ingelheim Reach Settlement Agreement with Ranbaxy on Flomax Patent Case
(PDF 9KB) |
| November 6,2007 |
Business resurlts for 1H/FY2007
|
| November 2,2007 |
Astellas Establishes a Liaison Office in India
(PDF 23KB) |
| October 23,2007 |
Theravance Receives FDA Approvable Letter for Telavancin for the Treatment of Complicated Skin and Skin Structure Infections
(PDF 39KB) |
| October 23,2007 |
ADENOSCAN® PATENT LAWSUITS SETTLED
(PDF 39KB) |
| October 22,2007 |
Announcement of the Acquisition of Marketing Approval for
the Pulmonary Arterial Hypertension Agent Careload® LA Tablets 60μg in Japan
(PDF 106KB) |
| October 4,2007 |
Announcement of the Launch of Geninax® Tablet,
an Oral New-Type Quinolone Antibacterial Agent, in Japan
(PDF 15KB) |
| October 3,2007 |
Astellas Completed the Early Retirement Program to Japanese Employees
(PDF 24KB) |
| September 19,2007 |
Astellas Submitted a Response to the FDA Action Letter for FK506 Modified Release Formulation for Kidney Transplantation
(PDF 26KB) |
| September 12,2007 |
Astellas Initiates Phase II Clinical Trials for Immunosuppressant, ASP0485
(PDF 25KB) |
| September 11,2007 |
Notice of Completion of Acquisition of the Company's Own Shares
(PDF 23KB) |
| September 10,2007 |
Court Dismisses Appeal Filed by Taiyo Yakuhin Co., Ltd. of Patent Infringement Suit
on Oral Cephalosporin Antibiotic Cefzon® Capsule
(PDF 27KB) |
| September 6,2007 |
Notice of the Result of Acquisition of the Company's Own Shares Through ToSTNeT-2
(PDF 23KB) |
| September 5,2007 |
Notice of Acquisition of the Company's Own Shares Through ToSTNeT-2
(PDF 25KB) |
| September 3,2007 |
Astellas Announces the Extension of US Regulatory Review for the sNDA of MYCAMINE®
(PDF 24KB) |
| August 31,2007 |
Cardiome and Astellas announce regulatory extention of RSD1235 in the US
|
| August 28,2007 |
Astellas Announces Acquisition of The Companyfs Own Shares
(Share buyback pursuant to the provision of its Articles of Incorporation in accordance with
Article 165, paragraph 2 of the Companies Act)
(PDF 23KB) |
| August 15,2007 |
Annual Report 2007
|
| August 10,2007 |
Contents of Stock Acquisition Rights
(Stock Option Scheme as Stock-Linked Compensation Plan)
(PDF 23KB) |
| August 9,2007 |
Astellas Filed a Lawsuit against Taiyo Yakuhin Co., Ltd. Claiming Damages on the
Oral Cephalosporin Antibiotic Cefzon®
(PDF 29KB) |
| August 1,2007 |
Business resurlts for 1Q/FY2007
|
| August 1,2007 |
Reorganization of Astellas European Business Function
(PDF 32KB) |
| July 26,2007 |
Allotment of Stock Acquisition Rights
(Stock Option Scheme as Stock-Linked Compensation Plan)
(PDF 58KB) |
| July 3,2007 |
Kyoto University and Astellas Co-research at the Innovation Center for Immunoregulation Technologies and Drugs of Next Generation
(PDF 13KB) |
| June 26,2007 |
Astellas Set Up The Nomination Committee and The Compensation Committee
(PDF 24KB) |
| June 18,2007 |
Astellas Announces the Launch of Advagraf® in the UK and Germany
(PDF 24KB) |
| June 11,2007 |
Announcement of the Launch of
the Selective COX-2 Inhibitor Celecox® Tablets in Japan
(PDF 15KB) |
| June 4,2007 |
The abstracts of results of Phase II studies in US and EU, and a Phase I study in Japan for the survivin expression inhibitor YM155 are available on the website of the 43rd American Society of Clinical Oncology (ASCO) annual meeting held during June 1 to 5, 2007.
|
| May 16,2007 |
addition of presentation slides for information meeting for FY2006 results
|
| May 15,2007 |
Announcement of FY2006 results
|
| May 15,2007 |
Partial Amendments to the Articles of Incorporation
(PDF 81KB) |
| May 15,2007 |
Issuance of Stock Acquisition Rights for Stock Option Scheme as Stock-Linked Compensation Plan
(PDF 28KB) |
| May 07,2007 |
Adverse Event of FG-2216 for the Treatment of Anemia
(PDF 26KB) |
| May 01,2007 |
Astellas and Theravance Announce Submission of Telavancin MAA for the Treatment of Complicated Skin and Soft Tissue Infections in Europe
(PDF 25KB) |
| Apr. 27,2007 |
Astellas Receives an European Commission Approval for Advagraf®
(PDF 24KB) |
| Apr. 26,2007 |
Astellas Will Set Up The Nomination Committee and The Compensation Committee
(PDF 24KB) |
| Apr. 26,2007 |
Astellas Nominates a Director and Corporate Auditors
(PDF 24KB) |
| Apr. 2,2007 |
Astellas Tokai Completed Merger with Two Group Companies
(PDF 24KB) |
| Mar. 30,2007 |
ASTELLAS LICENSES REGENERON'S VELOCIMMUNE®
TECHNOLOGY FOR DISCOVERING
HUMAN MONOCLONAL ANTIBODIES
(PDF 22KB) |
| Mar. 26,2007 |
Astellas Announces Cancellation of Treasury Stock
(PDF 24KB) |
| Mar. 26,2007 |
Astellas Assigns All Outstanding Shares of Its Production Subsidiary to Choseido
(PDF 24KB) |
| Mar. 20,2007 |
Astellas Receives an FDA Action Letter for Prograf sNDA
(PDF 27KB) |
| Mar. 2,2007 |
FDA APPROVES ASTELLAS' VAPRISOL® FOR THE TREATMENT OF HYPERVOLEMIC HYPONATREMIA
(PDF 59KB) |
| Feb. 28,2007 |
Astellas Constructs New Buildings at its Miyukigaoka Research Center in
Tsukuba
(PDF26KB) |
| Feb. 26,2007 |
Astellas Receives a Positive CHMP Opinion for EU Marketing Authorisation for FK506
Modified Release as a Once-Daily Immunosuppressant in Organ Transplantation
(PDF18KB) |
| Feb. 23,2007 |
ASTELLAS AND BOEHRINGER WON THE LAWSUIT AGAINST FLOMAX® GENERIC FOR PATENT INFRINGEMENT IN THE USA
(PDF23KB) |
| Feb. 13,2007 |
Contents of Stock Acquisition Rights
(Stock Option Scheme as Stock-Linked Compensation Plan)
(PDF 23KB) |
| Feb. 01,2007 |
Astellas Will Offer an Early Retirement Program to Japanese Employees
(PDF 24KB) |
| Feb. 01,2007 |
Business Results for 3Q/FY2006
|
| Jan. 29,2007 |
Notice of Intention to Exercise Call Option on 1.25% Convertible Bonds due 2014
(PDF23KB) |
| Jan. 26,2007 |
Astellas and Pfizer Reached Settlement on Declaratory Judgment Action relating to Lipitor Agreement
(PDF12KB) |
| Jan. 26,2007 |
Allotment of Stock Acquisition Rights(Stock Option Scheme as Stock-Linked Compensation Plan)
(PDF57KB) |
| Jan. 26,2007 |
Approval for Candin Antifungal Agent Funguard for Prophylaxis of Aspergillus and Candida infections in patients undergoing HSCT and
Immunosuppressant Prograf for Lupus Nephritis in Japan
(PDF17KB) |
| Jan. 26,2007 |
Announcement of the Acquisition of Marketing Approval for
the Selective COX-2 Inhibitor Celecox Tablet in Japan
(PDF12KB) |
| Jan. 24,2007 |
Kirin and Astellas Enter Into a Licensing Agreement
on an Immunosuppressive Fully Human Monoclonal Antibody
(PDF21KB) |
| Jan. 23,2007 |
Astellas Receives an Action Letter from FDA for NDA of FK506 MR in the U.S.
(PDF24KB) |
| Jan. 11,2007 |
Astellas Terminates Agreement on Acute Heart Failure Agent Carperitide
(PDF23KB) |
To view and print the files,